Photo from Karine Tawagi/X
Sep 30, 2024, 15:09
Karine Tawagi: Prostate CA panel at Uromigos on radioligands and future T cell engagers
Karine Tawagi, University of Illinois Chicago, shared a post on X:
“Prostate CA panel at Uromigos day 2 on:
radioligands:
-clinically meaningful SUV threshold?
-pre-chemo Lu-617 approvals in real world?
-issue with cytopenias -individualized dosimetry? PET q2cycles?
The future T cell engagers (ph1 Tarlatamab DLL3 in NEPC), beware CRS.”
Source: Karine Tawagi/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 09:22
Dec 21, 2024, 09:06
Dec 21, 2024, 09:00
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37
Dec 21, 2024, 08:29
Dec 21, 2024, 08:12